Ultragenyx Pharmaceutical
Trade Ultragenyx Pharmaceutical 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About RARE
Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza.
RARE Key Statistics
Stock Snapshot
As of today, Ultragenyx Pharmaceutical(RARE) shares are valued at $16.10. The company's market cap stands at 1.59B, with a P/E ratio of -2.75.
As of 2026-10-27, Ultragenyx Pharmaceutical(RARE) stock has fluctuated between $16.03 and $16.18. The current price stands at $16.10, placing the stock +0.4% above today's low and -0.5% off the high.
The Ultragenyx Pharmaceutical(RARE)'s current trading volume is 10.03K, compared to an average daily volume of 3.11M.
In the last year, Ultragenyx Pharmaceutical(RARE) shares hit a 52-week high of $39.89 and a 52-week low of $12.73.
In the last year, Ultragenyx Pharmaceutical(RARE) shares hit a 52-week high of $39.89 and a 52-week low of $12.73.
RARE News
Ultragenyx Pharmaceutical (RARE) has drawn attention after recent trading left the stock around US$15.65. Investors are weighing this price in relation to the f...
Analyst ratings
50%
of 22 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.